New DEA Buprenorphine Guidance The DEA issued guidance to DEA-registered physicians providing new flexibility for physicians managing patients with opioid use disorder. April 1, 2020 AMA AMA, Buprenorphine, Coronavirus, COVID-19, DEA, Opioids 0 0 Comment Read More »
